Onconetix Inc (ONCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 304 | 304 | 107 | 102 | 712 |
| Cost of Goods | 56 | 35 | 36 | 56 | 52 |
| Gross Profit | 248 | 269 | 71 | 46 | 660 |
| Operating Expenses | 1,585 | 2,373 | 2,042 | 12,673 | 29,858 |
| Operating Income | -1,281 | -2,069 | -1,935 | -12,571 | -29,146 |
| Interest Expense | 4 | 300 | 223 | 224 | 248 |
| Other Income | 6,956 | -6,414 | -214 | 4,249 | -962 |
| Pre-tax Income | 5,670 | -8,784 | -2,372 | -8,546 | -30,356 |
| Income Tax | N/A | N/A | N/A | N/A | -918 |
| Net Income Continuous | 5,670 | -8,784 | -2,372 | -8,546 | -29,438 |
| Net Income | $5,670 | $-8,784 | $-2,372 | $-8,546 | $-29,438 |
| EPS Basic Total Ops | 196.83 | -31.25 | -23.80 | -224.58 | 11,594.88 |
| EPS Basic Continuous Ops | 176.54 | -31.25 | -20.90 | -199.22 | 11,627.19 |
| EPS Diluted Total Ops | 196.83 | -31.25 | -23.80 | -224.58 | 11,594.88 |
| EPS Diluted Continuous Ops | 176.54 | -31.25 | -20.90 | -199.22 | 11,627.19 |
| EPS Diluted Before Non-Recurring Items | 62.90 | -31.25 | -20.25 | 105.93 | N/A |
| EBITDA(a) | $-1,274 | $-1,951 | $-1,932 | $-12,561 | $-18,376 |